Skip to main content
Diabetes
- Comparing metformin and glyburide in a combination medication as well as monotherapy in the treatment of diabetes mellitus type II
- Comparing exenatide versus insulin glargine in the treatment of diabetes mellitus type II
- Comparing insulin glulisine vs. insulin lispro for treating type II diabetes
- Rosiglitazone vs. pioglitazone for treating type II diabetes
- Rosiglitazone vs. pioglitazone for diabetic patients at risk for coronary heart disease
- Rosiglitazone vs. insulin for diabetic patients at risk for coronary heart disease
- Pioglitazone vs. insulin for diabetic patients at risk for coronary heart disease
- Liraglutide vs. glimepiride to treat type II diabetes
- Metformin vs. Actos for treating diabetes
- Comparing liraglutide to exenatide for treating type II diabetes
- Diet and exercise versus pioglitazone for treating obesity
- Insulin glulisine vs. insulin lispro for treating diabetes
- Comparing metformin to sulfonylureas: cardiovascular and all-cause mortality
- Metformin and glimepiride vs. metformin and empagliflozin for treating type 2 diabetes
- Exenatide vs. glimepiride for treating type 2 diabetes
- Vildagliptin versus metformin for treating type 2 diabetes
Osteoporosis
- Alendronate vs. risedronate for treating osteoporosis
- Teriparatide and denosumab versus teriparatide alone for treating osteoporosis
- Teriparatide and denosumab versus denosumab alone for treating osteoporosis
- Ibandronate versus risedronate for treating osteoporosis
- Romosozumab versus alendronate for preventing fractures in women with osteoporosis
- Ibandronate versus alendronate for treating osteoporosis
